RecruitingNot applicableNCT06080841
Curcumin Supplementation in Cervical Cancer
Studying Paraneoplastic cerebellar degeneration
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Cancerología
- Principal Investigator
- Denisse Castro, RDN, PhDConacyt / National Cancer Institute of Mexico
- Intervention
- Curcumin(dietary_supplement)
- Enrollment
- 30 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2023 – 2026
Study locations (1)
- Instituto Nacional de Cancerología, Mexico City, Mexico City, Mexico
Collaborators
Sabinsa Corporation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06080841 on ClinicalTrials.govOther trials for Paraneoplastic cerebellar degeneration
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07144280A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)Pfizer
- RECRUITINGNCT06965166Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal CancerMayo Clinic
- ACTIVE NOT RECRUITINGPHASE2NCT05557591A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)Regeneron Pharmaceuticals
- ACTIVE NOT RECRUITINGPHASE1NCT05338775A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple MyelomaJanssen Research & Development, LLC